| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
New Gold Inc.
| TSE
|
NGD
|
6.89
|
|
+0.18
(2.68%)
| 3.29B
|
|
|
New Gold Inc. is engaged in gold mining and related activities, including
acquisition, exploration, extraction, processing and reclamation.
| |
| |
|
|
New Gold Inc. (USA)
| NYSEMKT
|
NGD
|
6.64
|
|
+0.10
(1.53%)
| 3.17B
|
|
|
New Gold Inc. is engaged in gold mining and related activities, including
acquisition, exploration, extraction, processing and reclamation.
| |
| |
|
|
LYXOR ETF FT.E./N.G.D.DEO
| FRA
|
LYPP
|
38.84
|
|
-0.01
(-0.03%)
|
|
|
|
|
|
|
Merck & Co., Inc.
| NYSE
|
MRK
|
46.71
|
|
-0.62
(-1.31%)
| 141.17B
|
|
|
Merck & Co., Inc. (Merck) is a global health care company that delivers health
solutions through its prescription medicines, vaccines, biologic therapies, ...
| |
| |
|
|
MERCK AND CO INC
| EPA
|
MRK
|
37.15
|
|
+2.04
(5.81%)
|
|
|
|
|
|
|
MERCK CO. DL-,01
| FRA
|
6MK
|
37.19
|
|
+1.87
(5.29%)
|
|
|
|
|
|
|
Ligand Pharmaceuticals Inc.
| NASDAQ
|
LGND
|
27.38
|
|
-0.36
(-1.30%)
| 554.03M
|
|
|
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that
operates with a business model focused on developing or acquiring assets.
| |
| |
|
|
LIGAND PHARMAC.NEW DL-001
| FRA
|
LGDN
|
21.05
|
|
+0.07
(0.34%)
|
|
|
|
|
|
